HUT68130A - Process for preparing 3-amino-2-phenylpiperidine - Google Patents

Process for preparing 3-amino-2-phenylpiperidine

Info

Publication number: HUT68130A
Authority: HU; Hungary
Prior art keywords: phenylpiperidine; amino; preparing; aminopiperidine; divisional
Prior art date: 1990-01-04

Application number

HU9203403A

Other languages

English (en)

Inventor

Manoj Chandrasinhji Desai

Terry Jay Rosen

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-01-04

Filing date

1991-01-02

Publication date

1995-05-29

1991-01-02 Application filed by Pfizer filed Critical Pfizer

1995-05-29 Publication of HUT68130A publication Critical patent/HUT68130A/hu

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D211/74—Oxygen atoms
- C07D211/76—Oxygen atoms attached in position 2 or 6
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Immunology (AREA)
Psychiatry (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Addiction (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Dermatology (AREA)
Hydrogenated Pyridines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Pyrrole Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)

HU9203403A 1990-01-04 1991-01-02 Process for preparing 3-amino-2-phenylpiperidine HUT68130A (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/US1990/000116 WO1991009844A1 (en)	1990-01-04	1990-01-04	Substance p antagonists

Publications (1)

Publication Number	Publication Date
HUT68130A true HUT68130A (en)	1995-05-29

Family

ID=22220614

Family Applications (5)

Application Number	Title	Priority Date	Filing Date
HU9203403A HUT68130A (en)	1990-01-04	1991-01-02	Process for preparing 3-amino-2-phenylpiperidine
HU9203405A HUT68179A (en)	1990-01-04	1991-01-02	Process for preparing 3-amino-piperidine derivatives and related heterocyclic compounds containing nitrogen
HU9203404A HU220602B1 (hu)	1990-01-04	1991-01-02	Eljárás 3-amino-piperidin-származékok előállítására
HU916A HUT60719A (en)	1990-01-04	1991-01-02	Process for producing 3-aminopiperidine derivatives
HU9203403A HU222724B1 (hu)	1990-01-04	1991-01-02	Eljárás 3-amino-2-fenil-piperidin elżállítására

Family Applications After (4)

Application Number	Title	Priority Date	Filing Date
HU9203405A HUT68179A (en)	1990-01-04	1991-01-02	Process for preparing 3-amino-piperidine derivatives and related heterocyclic compounds containing nitrogen
HU9203404A HU220602B1 (hu)	1990-01-04	1991-01-02	Eljárás 3-amino-piperidin-származékok előállítására
HU916A HUT60719A (en)	1990-01-04	1991-01-02	Process for producing 3-aminopiperidine derivatives
HU9203403A HU222724B1 (hu)	1990-01-04	1991-01-02	Eljárás 3-amino-2-fenil-piperidin elżállítására

Country Status (27)

Country	Link
EP (2)	EP0436334B1 (hu)
JP (1)	JPH0757748B2 (hu)
KR (1)	KR930009441B1 (hu)
CN (2)	CN1035944C (hu)
AT (1)	ATE115127T1 (hu)
AU (1)	AU625511B2 (hu)
BR (1)	BR9100016A (hu)
CA (1)	CA2033497C (hu)
CZ (1)	CZ289485B6 (hu)
DE (1)	DE69014848T2 (hu)
DK (1)	DK0436334T3 (hu)
ES (1)	ES2064667T3 (hu)
FI (2)	FI114096B (hu)
GR (1)	GR3014940T3 (hu)
HU (5)	HUT68130A (hu)
IE (1)	IE63770B1 (hu)
IL (3)	IL96821A (hu)
MY (1)	MY105438A (hu)
NO (1)	NO178187C (hu)
NZ (1)	NZ236581A (hu)
PL (5)	PL164205B1 (hu)
PT (1)	PT96405B (hu)
RU (1)	RU2105758C1 (hu)
UA (1)	UA41251C2 (hu)
WO (1)	WO1991009844A1 (hu)
YU (1)	YU48026B (hu)
ZA (1)	ZA9136B (hu)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830863A (en) *	1988-06-20	1998-11-03	Merrell Pharmaceuticals Inc.	Neurokinin A antagonists
US6218364B1 (en)	1988-06-20	2001-04-17	Scott L. Harbeson	Fluorinated neurokinin A antagonists
US5332817A (en) *	1990-01-04	1994-07-26	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles
US5232929A (en) *	1990-11-28	1993-08-03	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
AU648558B2 (en) *	1990-05-31	1994-04-28	Pfizer Inc.	Preparation of substituted piperidines
US5364943A (en) *	1991-11-27	1994-11-15	Pfizer Inc.	Preparation of substituted piperidines
AU648317B2 (en) *	1990-06-01	1994-04-21	Pfizer Inc.	3-amino-2-aryl quinuclidines, process for their preparation and pharmaceutical compositions containing them
ATE116317T1 (de) *	1990-07-23	1995-01-15	Pfizer	Chinuclidinderivate.
JPH0794440B2 (ja) *	1991-03-26	1995-10-11	フアイザー・インコーポレイテツド	置換ピペリジンの立体選択的製造
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
HU221634B1 (hu) *	1991-06-20	2002-12-28	Pfizer Inc.	Nitrogéntartalmú heterociklusos vegyületek fluor-alkoxi-benzilamino-származékai, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények
TW202432B (hu) *	1991-06-21	1993-03-21	Pfizer
ATE136885T1 (de) *	1991-08-20	1996-05-15	Merck Sharp & Dohme	Azacyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
ES2149767T5 (es) *	1991-09-20	2005-06-16	Glaxo Group Limited	Nuevo uso medico para antagonistas de taquiquininas.
GB9201179D0 (en) *	1992-01-21	1992-03-11	Glaxo Group Ltd	Chemical compounds
FR2688219B1 (fr)	1992-03-03	1994-07-08	Sanofi Elf	Sels d'ammonium quaternaires de composes aromatiques amines, leur preparation et compositions pharmaceutiques les contenant.
US5444074A (en) *	1992-04-15	1995-08-22	Merck Sharp & Dohme Limited	Piperidine tachykinin receptor antagonists
CA2133077A1 (en) *	1992-04-15	1993-10-28	Raymond Baker	Azacyclic compounds
EP0641328B1 (en) *	1992-05-18	2001-11-21	Pfizer Inc.	Bridged aza-bicyclic derivatives as substance p antagonists
US5637699A (en) *	1992-06-29	1997-06-10	Merck & Co., Inc.	Process for preparing morpholine tachykinin receptor antagonists
CA2099233A1 (en) *	1992-06-29	1993-12-30	Conrad P. Dorn	Morpholine and thiomorpholine tachykinin receptor antagonists
US5719147A (en) *	1992-06-29	1998-02-17	Merck & Co., Inc.	Morpholine and thiomorpholine tachykinin receptor antagonists
US6048859A (en)	1992-06-29	2000-04-11	Merck & Co., Inc.	Morpholine and thiomorpholine tachykinin receptor antagonists
AU675447B2 (en) *	1992-07-28	1997-02-06	Merck Sharp & Dohme Limited	Carboxamidomethyl piperidine and analogues
EP0654029A1 (en) *	1992-08-04	1995-05-24	Pfizer Inc.	3-benzylamino-2-phenyl-piperidine derivatives as substance p receptor antagonists
GB9216911D0 (en) *	1992-08-10	1992-09-23	Merck Sharp & Dohme	Therapeutic agents
US5387595A (en) *	1992-08-26	1995-02-07	Merck & Co., Inc.	Alicyclic compounds as tachykinin receptor antagonists
WO1994005625A1 (en) *	1992-09-10	1994-03-17	Merck Sharp & Dohme Limited	Alcohols and ethers with aromatic substituents as tachykinin-antagonists
GB9220286D0 (en) *	1992-09-25	1992-11-11	Merck Sharp & Dohme	Therapeutic agents
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
US6369074B1 (en) *	1992-12-10	2002-04-09	Pfizer Inc.	Aminomethylene substituted non-aromatic heterocycles and use as substance P antagonists
ATE194340T1 (de) *	1992-12-10	2000-07-15	Pfizer	Aminomethylen substituierte heterocyclische verbindungen und ihre verwendung alssubstanz p antagonisten
US5830854A (en) *	1992-12-14	1998-11-03	Merck Sharp & Dohme, Limited	Method of treating cystic fibrosis using a tachykinin receptor antagonist
GB9300051D0 (en) *	1993-01-04	1993-03-03	Merck Sharp & Dohme	Therapeutic agents
US5633266A (en) *	1993-02-18	1997-05-27	Merck Sharp & Dohme Ltd.	Azacyclic compounds compositions containing them and their use as tachykinin antagonists
US5496833A (en) *	1993-04-13	1996-03-05	Merck Sharp & Dohme Limited	Piperidine tachykinin receptor antagonists
ES2105664T3 (es) *	1993-05-28	1997-10-16	Pfizer	Procedimiento para la preparacion y resolucion de 2-fenil-3-aminopiperidina.
US5348955A (en) *	1993-06-22	1994-09-20	Merck & Co., Inc.	N,N-diacylpiperazines
GB9317104D0 (en) *	1993-08-17	1993-09-29	Zeneca Ltd	Therapeutic heterocycles
US6083943A (en) *	1993-09-17	2000-07-04	Pfizer Inc	Substituted azaheterocyclecarboxylic acid
WO1995007908A1 (en) *	1993-09-17	1995-03-23	Pfizer Inc.	Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
EP0719253B1 (en) *	1993-09-17	2004-04-28	Pfizer Inc.	3-amino-5-carboxy-substituted piperidines and 3-amino-4-carboxy-substituted pyrrolidines as tachykinin antagonists
IS4208A (is) *	1993-09-22	1995-03-23	Glaxo Group Limited	3-(tetrazólýl-benzyl)amínó-piperadidín afleiður
TW263498B (hu) *	1993-11-10	1995-11-21	Takeda Pharm Industry Co Ltd
JPH09508376A (ja) *	1994-01-28	1997-08-26	メルクシヤープエンドドームリミテツド	アラルキル置換アザシクロ系の治療薬
US5610165A (en) *	1994-02-17	1997-03-11	Merck & Co., Inc.	N-acylpiperidine tachykinin antagonists
IL112778A0 (en) *	1994-03-04	1995-05-26	Merck & Co Inc	Substituted heterocycles, their preparation and pharmaceutical compositions containing them
GB9408872D0 (en) *	1994-05-03	1994-06-22	Zeneca Ltd	Heterocyclic compounds
GB9418545D0 (en) *	1994-09-15	1994-11-02	Merck Sharp & Dohme	Therapeutic agents
FR2725900B1 (fr) *	1994-10-21	1997-07-18	Sanofi Sa	Utilisation d'antagonistes des recepteurs nk1 pour la preparation de medicaments a action cardioregulatrice
EP0709375B1 (en) *	1994-10-25	2005-05-18	AstraZeneca AB	Therapeutic heterocycles
US5998444A (en) *	1995-10-24	1999-12-07	Zeneca Ltd.	Piperidinyl compounds as NK1 or NK2 antagonists
US6008223A (en) *	1994-10-27	1999-12-28	Zeneca Limited	Therapeutic compounds
FR2728166A1 (fr)	1994-12-19	1996-06-21	Oreal	Composition topique contenant un antagoniste de substance p
FR2728165A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene
FR2728169A1 (fr)	1994-12-19	1996-06-21	Oreal	Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales
FR2729954B1 (fr) *	1995-01-30	1997-08-01	Sanofi Sa	Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729952B1 (fr) *	1995-01-30	1997-04-18	Sanofi Sa	Composes heterocycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2741262B1 (fr)	1995-11-20	1999-03-05	Oreal	Utilisation d'un antagoniste de tnf-alpha pour le traitement des rougeurs cutanees d'origine neurogene
ATE223896T1 (de)	1995-12-21	2002-09-15	Pfizer	3-((5-substituierte benzyl)amino)-2- phenylpiperidine als substance-p-antagonisten
WO1998014193A1 (en) *	1996-10-04	1998-04-09	Alcon Laboratories, Inc.	The use of a substance p antagonist for the manufacture of a medicament for the treatment of ocular pain
US5750549A (en) *	1996-10-15	1998-05-12	Merck & Co., Inc.	Cycloalkyl tachykinin receptor antagonists
CA2287487A1 (en) *	1997-04-24	1998-10-29	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating eating disorders
GB9716457D0 (en) *	1997-08-04	1997-10-08	Merck Sharp & Dohme	Therapeutic agents
AU738047B2 (en) *	1997-08-04	2001-09-06	Merck Sharp & Dohme Limited	Use of NK-1 receptor antagonists for treating mania
GB9716463D0 (en) *	1997-08-04	1997-10-08	Merck Sharp & Dohme	Therapeutic agents
WO1999007375A1 (en) *	1997-08-04	1999-02-18	Merck Sharp & Dohme Limited	Use of nk-1 receptor antagonists for treating aggressive behaviour disorders
GB9816897D0 (en) *	1998-08-04	1998-09-30	Merck Sharp & Dohme	Therapeutic use
ATE238044T1 (de) *	1998-08-25	2003-05-15	Novartis Pharma Gmbh	Verwendung von substanz p antagonisten zur behandlung des chronischen ermüdungssyndroms und/oder der fibromyalgie
CA2389306C (en)	1999-11-03	2010-03-30	Albany Molecular Research, Inc.	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
CZ20023168A3 (cs)	2000-03-21	2003-02-12	Smithkline Beecham Corporation	Inhibitory proteázy
BR0112350A (pt)	2000-07-11	2003-06-24	Albany Molecular Res Inc	Composto, composição farmacêutica, e, método de tratar um animal afligido por um distúrbio neurológico ou psicológico
AU2001292320A1 (en) *	2000-10-02	2002-04-15	Tanabe Seiyaku Co., Ltd.	Benzylamine compound, process for producing the same, and intermediate therefor
US6709651B2 (en)	2001-07-03	2004-03-23	B.M.R.A. Corporation B.V.	Treatment of substance P-related disorders
AU2002360046A1 (en) *	2001-12-28	2003-07-24	Takeda Chemical Industries, Ltd.	Nitrogenous cyclic ketone derivative, process for producing the same, and use
US7220098B2 (en)	2003-05-27	2007-05-22	General Electric Company	Wear resistant variable stator vane assemblies
AU2005274927B2 (en)	2004-07-15	2011-11-03	Albany Molecular Research, Inc.	Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CA2584422A1 (en)	2004-10-18	2006-04-27	Eli Lilly And Company	1-(hetero)aryl-3-amino-pyrollidine derivatives for use as mglur3 receptor antagonists
GB0423356D0 (en) *	2004-10-21	2004-11-24	Merck Sharp & Dohme	Therapeutic agents
US7543992B2 (en)	2005-04-28	2009-06-09	General Electric Company	High temperature rod end bearings
ATE550019T1 (de)	2005-05-17	2012-04-15	Merck Sharp & Dohme	Cis-4-ä(4-chlorophenyl)sulfonylü-4-(2,5- difluorophenyl)cyclohexanepropansäure zur behandlug von krebs
JP5258561B2 (ja)	2005-07-15	2013-08-07	アルバニーモレキュラーリサーチ，インコーポレイテッド	アリール置換およびヘテロアリール置換テトラヒドロベンズアゼピンならびにノルエピネフリン、ドーパミンおよびセロトニンの再取り込みを遮断するためのその使用
AU2006297443B2 (en)	2005-09-29	2010-08-12	Merck Sharp & Dohme Corp.	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
JP5489333B2 (ja)	2006-09-22	2014-05-14	メルク・シャープ・アンド・ドーム・コーポレーション	脂肪酸合成阻害剤を用いた治療の方法
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
PL2805945T3 (pl)	2007-01-10	2019-09-30	Msd Italia S.R.L.	Indazole podstawione grupą amidową jako inhibitory polimerazy poli(adp-rybozy) - (parp)
CN101641099A (zh)	2007-01-24	2010-02-03	葛兰素集团有限公司	包含3,5-二氨基-6-(2,3-二氯苯基)-1,2,4-三嗪或r(-)-2,4-二氨基-5-(2,3-二氯苯基)-6-氟甲基嘧啶和nk1的药物组合物
CA2682727C (en)	2007-04-02	2016-03-22	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
CA2690191C (en)	2007-06-27	2015-07-28	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
CN102014631A (zh)	2008-03-03	2011-04-13	泰格尔医药科技公司	酪氨酸激酶抑制剂
AR071997A1 (es)	2008-06-04	2010-07-28	Bristol Myers Squibb Co	Forma cristalina de 6-((4s)-2-metil-4-(2-naftil)-1,2,3,4-tetrahidroisoquinolin-7-il)piridazin-3-amina
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (ru)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Бензоксазины, бензотиазины и родственные соединения, которые имеют ингибирующую nos активность
CA2746967A1 (en) *	2009-01-27	2010-08-05	F. Hoffmann-La Roche Ag	Aroylamino - and heteroaroylamino-substituted piperidines as glyt-1 inhibitors
EP2413932A4 (en)	2009-04-01	2012-09-19	Merck Sharp & Dohme	INHIBITORS OF AKT ACTIVITY
CN102595902B (zh)	2009-05-12	2015-04-29	阿尔巴尼分子研究公司	7-([1,2,4]三唑并[1,5-a]吡啶-6-基)-4-(3,4-二氯苯基)-1,2,3,4-四氢异喹啉及其用途
ES2528404T3 (es)	2009-05-12	2015-02-10	Bristol-Myers Squibb Company	Formas cristalinas de (S)-7-([1,2,4]triazol[1,5-a]piridin-6-il)-4-(3,4-diclorofenil)-1,2,3,4-tetrahidroisoquinolina y sus usos
WO2010132437A1 (en)	2009-05-12	2010-11-18	Albany Molecular Research, Inc.	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
NZ599343A (en)	2009-10-14	2014-05-30	Merck Sharp & Dohme	Substituted piperidines that increase p53 activity and the uses thereof
EP2584903B1 (en)	2010-06-24	2018-10-24	Merck Sharp & Dohme Corp.	Novel heterocyclic compounds as erk inhibitors
WO2012018754A2 (en)	2010-08-02	2012-02-09	Merck Sharp & Dohme Corp.	RNA INTERFERENCE MEDIATED INHIBITION OF CATENIN (CADHERIN-ASSOCIATED PROTEIN), BETA 1 (CTNNB1) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
EP4079856A1 (en)	2010-08-17	2022-10-26	Sirna Therapeutics, Inc.	Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina)
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
EP2613782B1 (en)	2010-09-01	2016-11-02	Merck Sharp & Dohme Corp.	Indazole derivatives useful as erk inhibitors
WO2012036997A1 (en)	2010-09-16	2012-03-22	Schering Corporation	Fused pyrazole derivatives as novel erk inhibitors
ES2663009T3 (es)	2010-10-29	2018-04-10	Sirna Therapeutics, Inc.	Inhibición de la expresión génica mediada por interferencia por ARN utilizando ácidos nucleicos de interferencia cortos (ANic)
EP2654748B1 (en)	2010-12-21	2016-07-27	Merck Sharp & Dohme Corp.	Indazole derivatives useful as erk inhibitors
CA2831730A1 (en)	2011-04-21	2012-10-26	Piramal Enterprises Limited	A crystalline form of a salt of a morpholino sulfonyl indole derivative and a process for its preparation
US9023865B2 (en)	2011-10-27	2015-05-05	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
EP3453762B1 (en)	2012-05-02	2021-04-21	Sirna Therapeutics, Inc.	Short interfering nucleic acid (sina) compositions
US9233979B2 (en)	2012-09-28	2016-01-12	Merck Sharp & Dohme Corp.	Compounds that are ERK inhibitors
WO2014078568A1 (en)	2012-11-14	2014-05-22	The Johns Hopkins University	Methods and compositions for treating schizophrenia
BR112015012295A8 (pt)	2012-11-28	2023-03-14	Merck Sharp & Dohme	Uso de um inibidor de wee1, e, kit para identificar um paciente com câncer
BR112015013611A2 (pt)	2012-12-20	2017-11-14	Merck Sharp & Dohme	composto, e, composição farmacêutica
US9540377B2 (en)	2013-01-30	2017-01-10	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
US10975084B2 (en)	2016-10-12	2021-04-13	Merck Sharp & Dohme Corp.	KDM5 inhibitors
WO2019094311A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP3706747B1 (en)	2017-11-08	2025-09-03	Merck Sharp & Dohme LLC	Prmt5 inhibitors
CA3091944A1 (en) *	2018-02-26	2019-08-29	Ospedale San Raffaele S.R.L.	Nk-1 antagonists for use in the treatment of ocular pain
EP3833667B1 (en)	2018-08-07	2024-03-13	Merck Sharp & Dohme LLC	Prmt5 inhibitors
EP3833668B1 (en)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Prmt5 inhibitors
AU2019317549A1 (en)	2018-08-07	2021-02-25	Msd International Gmbh	PRMT5 inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL89969C (hu) *	1954-02-05
GB1060160A (en) *	1964-08-05	1967-03-01	Allen & Hanburys Ltd	4-phenylpiperidine derivatives
US3560510A (en) *	1969-03-05	1971-02-02	Aldrich Chem Co Inc	2-benzhydrylquinuclidines
US3992389A (en) *	1970-09-03	1976-11-16	John Wyeth & Brother Limited	Heterocyclic compounds
MX18467A (es) *	1988-11-23	1993-07-01	Pfizer	Agentes terapeuticos de quinuclidinas
AU648558B2 (en) *	1990-05-31	1994-04-28	Pfizer Inc.	Preparation of substituted piperidines

1990
- 1990-01-04 UA UA5010406A patent/UA41251C2/uk unknown
- 1990-01-04 WO PCT/US1990/000116 patent/WO1991009844A1/en unknown
- 1990-12-14 ES ES90313680T patent/ES2064667T3/es not_active Expired - Lifetime
- 1990-12-14 EP EP90313680A patent/EP0436334B1/en not_active Expired - Lifetime
- 1990-12-14 DK DK90313680.2T patent/DK0436334T3/da active
- 1990-12-14 DE DE69014848T patent/DE69014848T2/de not_active Expired - Fee Related
- 1990-12-14 EP EP19930201034 patent/EP0558156A3/en not_active Ceased
- 1990-12-14 AT AT90313680T patent/ATE115127T1/de not_active IP Right Cessation
- 1990-12-20 NZ NZ236581A patent/NZ236581A/xx unknown
- 1990-12-28 IL IL96821A patent/IL96821A/xx not_active IP Right Cessation
- 1990-12-28 IL IL112348A patent/IL112348A/en not_active IP Right Cessation
- 1990-12-28 JP JP2409476A patent/JPH0757748B2/ja not_active Expired - Fee Related
1991
- 1991-01-02 HU HU9203403A patent/HUT68130A/hu unknown
- 1991-01-02 PL PL91293392A patent/PL164205B1/pl not_active IP Right Cessation
- 1991-01-02 AU AU68621/91A patent/AU625511B2/en not_active Ceased
- 1991-01-02 MY MYPI91000002A patent/MY105438A/en unknown
- 1991-01-02 PT PT96405A patent/PT96405B/pt active IP Right Grant
- 1991-01-02 PL PL91293390A patent/PL164203B1/pl not_active IP Right Cessation
- 1991-01-02 HU HU9203405A patent/HUT68179A/hu unknown
- 1991-01-02 HU HU9203404A patent/HU220602B1/hu unknown
- 1991-01-02 PL PL91293391A patent/PL164204B1/pl not_active IP Right Cessation
- 1991-01-02 CA CA002033497A patent/CA2033497C/en not_active Expired - Fee Related
- 1991-01-02 PL PL91293389A patent/PL164244B1/pl unknown
- 1991-01-02 PL PL91288592A patent/PL163967B1/pl not_active IP Right Cessation
- 1991-01-02 HU HU916A patent/HUT60719A/hu unknown
- 1991-01-02 HU HU9203403A patent/HU222724B1/hu not_active IP Right Cessation
- 1991-01-03 ZA ZA9136A patent/ZA9136B/xx unknown
- 1991-01-03 BR BR919100016A patent/BR9100016A/pt not_active Application Discontinuation
- 1991-01-03 YU YU491A patent/YU48026B/sh unknown
- 1991-01-03 NO NO910016A patent/NO178187C/no unknown
- 1991-01-03 KR KR1019910000001A patent/KR930009441B1/ko not_active Expired - Fee Related
- 1991-01-03 FI FI910034A patent/FI114096B/fi active
- 1991-01-03 IE IE791A patent/IE63770B1/en not_active IP Right Cessation
- 1991-01-03 CN CN91100039A patent/CN1035944C/zh not_active Expired - Fee Related
- 1991-01-04 CZ CS199110A patent/CZ289485B6/cs not_active IP Right Cessation
- 1991-12-23 RU SU5010406A patent/RU2105758C1/ru not_active IP Right Cessation
1993
- 1993-08-20 CN CN93116286A patent/CN1045595C/zh not_active Expired - Fee Related
1995
- 1995-01-16 IL IL11234895A patent/IL112348A0/xx unknown
- 1995-02-01 GR GR950400206T patent/GR3014940T3/el unknown
2004
- 2004-04-01 FI FI20040479A patent/FI20040479A7/fi not_active Application Discontinuation

Also Published As

Publication number	Publication date
IE63770B1 (en)	1995-06-14
PL293389A1 (en)	1992-07-13
DE69014848T2 (de)	1995-05-04
WO1991009844A1 (en)	1991-07-11
HU220602B1 (hu)	2002-03-28
PL164244B1 (en)	1994-07-29
DK0436334T3 (da)	1995-02-13
PL288592A1 (en)	1992-06-15
IL112348A0 (en)	1995-03-30
IE910007A1 (en)	1991-07-17
PL164203B1 (pl)	1994-06-30
NO910016D0 (no)	1991-01-03
PL293391A1 (en)	1992-07-13
PL293390A1 (en)	1992-07-13
DE69014848D1 (de)	1995-01-19
HUT68180A (en)	1995-05-29
NO178187B (no)	1995-10-30
KR930009441B1 (ko)	1993-10-04
FI910034L (fi)	1991-07-05
CN1045595C (zh)	1999-10-13
PL163967B1 (pl)	1994-06-30
CS1091A3 (en)	1991-08-13
CA2033497A1 (en)	1991-07-05
CN1087083A (zh)	1994-05-25
EP0558156A2 (en)	1993-09-01
AU625511B2 (en)	1992-07-16
PT96405A (pt)	1991-10-15
YU48026B (sh)	1996-10-09
PL164205B1 (en)	1994-06-30
ATE115127T1 (de)	1994-12-15
CN1053060A (zh)	1991-07-17
JPH0757748B2 (ja)	1995-06-21
CA2033497C (en)	1997-01-07
CN1035944C (zh)	1997-09-24
HUT60719A (en)	1992-10-28
KR910014350A (ko)	1991-08-31
JPH04103570A (ja)	1992-04-06
ES2064667T3 (es)	1995-02-01
FI910034A0 (fi)	1991-01-03
HU910006D0 (en)	1991-08-28
HU222724B1 (hu)	2003-09-29
IL96821A (en)	1997-03-18
EP0436334A2 (en)	1991-07-10
PL293392A1 (en)	1992-07-13
AU6862191A (en)	1991-07-18
ZA9136B (en)	1992-08-26
BR9100016A (pt)	1991-10-22
CZ289485B6 (cs)	2002-02-13
PL164204B1 (pl)	1994-06-30
NO910016L (no)	1991-07-05
IL112348A (en)	1998-06-15
NO178187C (no)	1996-02-07
YU491A (sh)	1994-01-20
EP0558156A3 (en)	1993-10-06
IL96821A0 (en)	1991-09-16
EP0436334A3 (en)	1992-05-27
PT96405B (pt)	1998-06-30
MY105438A (en)	1994-10-31
EP0436334B1 (en)	1994-12-07
GR3014940T3 (en)	1995-05-31
NZ236581A (en)	1992-10-28
FI114096B (fi)	2004-08-13
HUT68179A (en)	1995-05-29
UA41251C2 (uk)	2001-09-17
RU2105758C1 (ru)	1998-02-27
FI20040479A7 (fi)	2004-04-01

Publication	Publication Date	Title
HUT68130A (en)	1995-05-29	Process for preparing 3-amino-2-phenylpiperidine
HU907113D0 (en)	1991-05-28	Process for producing analogues of 2', 3'-didesoxy-2'-fluoro-arabino-nucleoside
SG94591G (en)	1992-01-17	Process for preparation of (2,2)-paracyclophane
EP0445589A3 (en)	1991-11-21	Process for the preparation of 1,4-alkylenediamines
EP0389110A3 (en)	1990-12-19	Process for the preparation of 2'-deoxy-5-trifluoromethyl-beta-uridine
EP0297496A3 (en)	1990-06-20	Novel process for the preparation of 6,7-diacyl-7-deacetylforskolin derivatives
IL92465A0 (en)	1990-08-31	Process for the preparation of 4,4'-dibromodiphenylether
EP0475272A3 (en)	1992-07-01	Process for the preparation of 2,3,5-trimethyl-p-benzoquinone
HU900036D0 (en)	1990-03-28	Process for preparation of 2,4-diamino-6-pyperidinyl-pyrimidin-3-n-oxide
IL96182A0 (en)	1991-07-18	Process for the preparation of molluscicidal 2,4,5-tribromopyrrole-3-carbonitrile compounds
EP0297239A3 (en)	1990-05-02	Process for the preparation of hexadiin(2,4)-diol-1,6
PH24488A (en)	1990-07-18	Process for the preparation of aryl-pyrido (1,4)-benzodiazepines
GB8730298D0 (en)	1988-02-03	Novel aminoalkanoyl-dibenzo(d g)(1 3 6)dioxazocines & process for preparation thereof
CA2007653A1 (en)	1990-12-15	Process for the manufacture of anilinofumarate via chloromaleate or chlorofumarate or mixtures thereof
HU900754D0 (en)	1990-04-28	Process for preparation of n-substituted 3,4,5,6-tetrahydrophtalimides
GR3000499T3 (en)	1991-06-28	Process for the preparation of 9(11)-dehydroandrostanes
YU16590A (en)	1991-10-31	Process for preparing cyclical derivatives of 2',3'-seco-uridine
YU44618B (en)	1990-10-31	Process for preparation of derivatives (1,2,4-triazolyle)-2-propanol
YU25289A (en)	1990-12-31	Process for preparing new derivatives of 1,5-dihydro-(1,3)-dioxepino (5,6-c) pyridin-9-oles
IL87498A (en)	1993-08-18	Process for the preparation of 3,3(-disubstituted n-substituted b-lactams, and novel compounds obtained thereby
HU901781D0 (en)	1990-06-28	Process for the preparation of 17,18-dehydro-apovincaminol-ester
HU895806D0 (en)	1990-01-28	Process for the preparation of 17beta-hydroxy-pregna-4,9(11)-dien-3,20-dione derivatives
IE871153L (en)	1987-10-30	"process for the preparation of lmw-heparin"
IL93687A0 (en)	1990-12-23	Process for the preparation of 4,4'-dihydroxy-3-methyl-diphenylether